IGF2 and cardiac hypertrophy: In addition, IGF-2/IGF-2R induces pathological cardiac hypertrophy through the calcium/calmodulin-dependent protein kinase II (CaMKIIδ) and calcineurin signaling pathways, which can be alleviated by combining inhibitors of CaMKIIδ and calcineurin [87,93].